Description
The cyclic RGD peptide cilengitide is a potential cancer drug. Cilengitide is under investigation for the treatment of glioblastoma, where it may act by inhibiting angiogenesis, and influencing tumor invasion and proliferation.
Cilengitide
Price range: $82.40 through $311.40
The cyclic RGD peptide cilengitide is a potential cancer drug. Cilengitide is under investigation for the treatment of glioblastoma, where it may act by inhibiting angiogenesis, and influencing tumor invasion and proliferation.
Related products
-
((R)-4-Hydroxy-4-methyl-Orn(5-TAMRA)⁷)-Phalloidin
$931.00 -
((R)-4-Hydroxy-4-methyl-Orn(CPM-β-Mpa)⁷)-Phalloidin
$202.20 -
((R)-4-Hydroxy-4-methyl-Orn(TRITC)⁷)-Phalloidin
$343.74 -
(2-(1,3-Dithiolan-2-yl)-Trp²⁵)-Liraglutide trifluoroacetate salt
Price range: $443.00 through $2,635.40 -
(2-Hydroxy-Trp²⁵)-Liraglutide trifluoroacetate salt
Price range: $443.00 through $2,635.40